Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Vaccine for Oncology by CAS-Lamvac Biotech for Ovarian Cancer: Likelihood of Approval
Vaccine for Oncology is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Ovarian Cancer. According to...
Vaccine for Oncology by CAS-Lamvac Biotech for Colorectal Cancer: Likelihood of Approval
Vaccine for Oncology is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Colorectal Cancer. According to...
Vaccine for Oncology by CAS-Lamvac Biotech for Liver Cancer: Likelihood of Approval
Vaccine for Oncology is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Liver Cancer. According to...
Vaccine for Oncology by CAS-Lamvac Biotech for Thyroid Cancer: Likelihood of Approval
Vaccine for Oncology is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Thyroid Cancer. According to...
Vaccine for Oncology by CAS-Lamvac Biotech for Brain Tumor: Likelihood of Approval
Vaccine for Oncology is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Brain Tumor. According to...
Vaccine for Oncology by CAS-Lamvac Biotech for Prostate Cancer: Likelihood of Approval
Vaccine for Oncology is under clinical development by CAS-Lamvac Biotech and currently in Phase II for Prostate Cancer. According to...